SCM
AGN

Suffolk Capital Management’s Allergan plc AGN Stock Holding History

Suffolk Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-58,077
Closed -$12.2M – 155
2016
Q4 		$12.2M Sell
58,077
-1,889
-3% -$391K 1.67% 25
2016
Q3 		$13.8M Sell
59,966
-1,780
-3% -$435K 1.9% 8
2016
Q2 		$14.3M Buy
61,746
+39,080
+172% +$9.01M 1.84% 7
2016
Q1 		$6.08M Sell
22,666
-24,651
-52% -$7.06M 0.81% 46
2015
Q4 		$14.8M Buy
47,317
+5,432
+13% +$1.62M 1.88% 9
2015
Q3 		$11.4M Sell
41,885
-7,758
-16% -$2.38M 1.51% 26
2015
Q2 		$15.1M Sell
49,643
-4,919
-9% -$1.47M 1.79% 6
2015
Q1 		$16.2M Sell
54,562
-1,637
-3% -$467K 1.9% 3
2014
Q4 		$14.5M Buy
56,199
+1,511
+3% +$378K 1.76% 9
2014
Q3 		$13.2M Buy
+54,688
New +$12.2M 1.64% 7

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Suffolk Capital Management's AGN Position: Q1 2017 in Review

Suffolk Capital Management sold out of Allergan plc (AGN) in Q1 2017, closing a stake of 58,077 shares — an estimated $12.2M sold.

Suffolk Capital Management first reported a position in AGN in Q3 2014 and held it in 10 quarters. The position peaked at $16.2M in Q1 2015. 1,104 funds tracked by Wall St. Rank hold AGN as of Q1 2017.

  • Suffolk Capital Management reported no remaining Allergan plc position as of Q1 2017 after selling out during the quarter.
  • Suffolk Capital Management sold 58,077 Allergan plc shares in Q1 2017, an estimated $12.2M.
  • Suffolk Capital Management first reported a position in Allergan plc in Q3 2014 and held it in 10 quarters.
  • Suffolk Capital Management's Allergan plc position peaked at $16.2M in Q1 2015.
  • 1,104 funds tracked by Wall St. Rank held Allergan plc as of Q1 2017.

Based on Suffolk Capital Management's 13F filing for Q1 2017, filed 11 May 2017.